At Kochi auctions, orthodox leaf sale sees strong demand from CIS countries
A strong demand from CIS countries lifted orthodox leaf tea prices at Kochi auctions this week. There was a strong...
Month: May 2020
European Businesses Must Prepare Now, Despite COVID-19
Add to favorites “European companies must get on top of how they are interacting with data, or risk leaving themselves...
Biosensing test to transform diseas… – Information Centre – Research & Innovation
EU-funded researchers have developed an ultrasensitive test to rapidly, accurately and cost-effectively diagnose disease, underpinned by innovative biosensing technology that...
Enlisting feathered friends to figh… – Information Centre – Research & Innovation
Illegal fishing destroys marine habitats and threatens species living at sea. An EU-funded project is helping authorities to crack down...
Mapping out policy priorities for a… – Information Centre – Research & Innovation
EU-funded researchers have mapped out possible pathways to achieve the drastic technological, economic and societal transformations needed for the EU...
Self-powered platform holds promise… – Information Centre – Research & Innovation
A single test strip - the first platform to couple a methanol fuel cell with a biosensor - could act...
Hardin Memorial Health improved communications in its ED, and patient satisfaction is soaring
When Kentucky-based Hardin Memorial Health doubled the size of its emergency department to better serve its growing population, the hospital...
Vanguard Digital Advisor—personalized online financial advice at your fingertips
Digital Advisor is built on the foundation of Vanguard’s time-tested investment methodology and enduring principles—having clear goals, creating a diversified...
Atul Gawande could step down as Haven CEO: report
Atul Gawande, who in 2018 was appointed CEO of Haven, the nonprofit healthcare venture launched by the founders of Amazon,...
New triple antiviral drug combination shows early promise for treating COVID-19 in phase 2 randomized trial
A two-week course of antiviral therapy with interferon beta-1b, plus lopinavir-ritonavir and ribavirin, started within seven days of showing COVID-19...
